Home > Pulmonology > ERS 2022 > Digital asthma intervention improves health and reduces costs

Digital asthma intervention improves health and reduces costs

Presented By
Mr Luca Ponti, Amiko Digital Health, Italy
ERS 2022
A pharmacy-supported digital medicine programme improved adherence to therapy and inhalation technique in patients with uncontrolled asthma, ultimately resulting in improved asthma control. Next to health benefits for the patients, the results suggest a potential for significant cost reductions. “Adherence to therapy and an adequate inhaler technique are essential for optimal asthma control,” explained Mr Luca Ponti (Amiko Digital Health, Italy). The current study compared a pharmacy-supported digital medicine programme, including inhaler sensors, mHealth apps, and in-person pharmacy-based counselling, with a traditional pharmacy-based patient support programme in 68 participants with uncontrolled asthma. The adherence to therapy was 82% in the experimental arm and 30–50% in the control arm. Furthermore, the digital intervention appeared to improve the rate of correct inhalation technique as compared with the control arm (64% vs 31%). Next, the auth...

Please login to read the full text of the article.

If you have no account yet, please register now.

Posted on